US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs, in exchange for relief from threatened tariffs.Both companies “have agreed to offer their most popular GLP-1 weight-loss drug,” Trump said at the White House, “at drastic discounts.
“”Eli Lilly and Novo Nordisk are committing to offer Zepbound and Wegovy at ‘Most Favored Nation’ rates for American patients,” Trump added, saying this would lower the costs of products fo
Continue Reading on The Guardian Nigeria
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.